Prospective Multicenter Study on Clinical Application of Sonozoid in Thyroid Tumor - Trial NCT04574258
Access comprehensive clinical trial information for NCT04574258 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese PLA General Hospital and is currently Completed. The study focuses on Ultrasound. Target enrollment is 371 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Chinese PLA General Hospital
Timeline & Enrollment
N/A
Oct 01, 2020
Aug 01, 2021
Primary Outcome
Diagnostic performance of contrast-enhanced ultrasound in thyroid tumor by Sonazoid.
Summary
Sonazoid as a new generation of ultrasound contrast agent. This study based on the features
 of Sonazoid specific angiography and high mechanical index, the role of Sonazoid in the
 differential diagnosis of thyroid benign and malignant tumors was explored.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04574258
Non-Device Trial